LOS ANGELES, CALIFORNIA / ACCESS Newswire / February 10, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes transforming abundant feedstock into valuable nutraceuticals and new medicines - announced the launch of a redesigned corporate website and updated visual identity, reflecting the company's refined strategic focus on pharmaceutical and nutraceutical markets. The update follows the company's previously communicated decision to sharpen its commercial scope toward s ...

Core Insights - eXoZymes Inc. is hosting a webinar to provide an operational update for Q3 2025, which ended on October 31, 2025 [1] Company Overview - eXoZymes is recognized as a pioneer in the development of AI-enhanced enzymes that convert sustainable feedstock into nutraceuticals and new medicines [1]